(2023)
Benefit of postoperative regional nodal irradiation in patients receiving preoperative systemic therapy with docetaxel/carboplatin/trastuzumab/pertuzumab for HER2-positive breast cancer.
BREAST.
72,
(2023)
Clinical activity of nivolumab in combination with eribulin in HER2-negative metastatic breast cancer: A phase IB/II study (KCSG BR18-16).
EUROPEAN JOURNAL OF CANCER.
195,
(2023)
A Retrospective Exploratory Analysis for Serum Extracellular Vesicles Reveals APRIL (TNFSF13), CXCL13, and VEGF-A as Prognostic Biomarkers for Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES.
24,
21
(2023)
Impact of high dose radiotherapy for breast tumor in locoregionally uncontrolled stage IV breast cancer: a need for a risk-stratified approach.
RADIATION ONCOLOGY.
18,
1
(2023)
Comprehensive Clinical Characterization of Decade-Long Survivors of Metastatic Breast Cancer.
CANCERS.
15,
19
(2023)
Pretreatment endocrine symptoms and recurrence-free survival among young premenopausal patients with breast cancer: a prospective cohort study.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY.
15,
(2023)
Longitudinal multi-omics study of palbociclib resistance in HR-positive/HER2-negative metastatic breast cancer.
GENOME MEDICINE.
15,
1
(2023)
Progesterone Receptor Expression Level Predicts Prognosis of Estrogen Receptor-Positive/HER2-Negative Young Breast Cancer: A Single-Center Prospective Cohort Study.
CANCERS.
15,
13
(2023)
Real World Experience of Second-Line Treatment Strategies after Palbociclib and Letrozole: Overall Survival in Metastatic Hormone Receptor-Positive Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer.
CANCERS.
15,
13
(2022)
Response Rate and Safety of a Neoadjuvant Pertuzumab, Atezolizumab, Docetaxel, and Trastuzumab Regimen for Patients With ERBB2-Positive Stage II/III Breast Cancer The Neo-PATH Phase 2 Nonrandomized Clinical Trial.
JAMA ONCOLOGY.
8,
9
(2022)
Improved Prediction of Survival Outcomes Using Residual Cancer Burden in Combination With Ki-67 in Breast Cancer Patients Underwent Neoadjuvant Chemotherapy.
FRONTIERS IN ONCOLOGY.
12,
(2022)
Development and validation of the Pediatric-Youth Hyperphagia Assessment for Prader-Willi syndrome.
EPIDEMIOLOGY AND HEALTH.
44,
